BRIM Biotechnology Management
Management criteria checks 0/4
BRIM Biotechnology's CEO is Wenqi Xu, appointed in Apr 2023, has a tenure of 1.75 years. directly owns 0.086% of the company’s shares, worth NT$2.86M. The average tenure of the management team and the board of directors is 1.8 years and 1.8 years respectively.
Key information
Wenqi Xu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.09% |
| Management average tenure | 1.8yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
CEO
Wenqi Xu
1.8yrs
Tenure
Dr. Wenqi Xu, Ph D., serves as Chief Executive Officer and General Manager at BRIM Biotechnology, Inc. since April 2023 and served as its Scientific Board Member until April 2023. Dr. Xu experience include...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & GM | 1.8yrs | no data | 0.086% NT$ 2.9m | |
| Vice Chairman & Chief Global Strategist | 1.8yrs | no data | 1.96% NT$ 65.1m | |
| Vice President of Finance & Accounting Supervisor | 1.8yrs | no data | 0.11% NT$ 3.8m | |
| Chief Operating Officer | 1.8yrs | no data | 0.14% NT$ 4.8m | |
| Chief Technology Officer | less than a year | no data | no data | |
| Chief Scientific Officer | 2yrs | no data | 0.95% NT$ 31.3m |
1.8yrs
Average Tenure
Experienced Management: 6885's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & Chief Global Strategist | 1.8yrs | no data | 1.96% NT$ 65.1m | |
| Scientific Board Member | no data | no data | no data | |
| Independent Director | 1.8yrs | no data | no data | |
| Chairman of the Board | 1.8yrs | no data | no data | |
| Scientific Board Member | no data | no data | no data | |
| Independent Director | 1.8yrs | no data | no data | |
| Director | no data | no data | 0.13% NT$ 4.2m | |
| Scientific Board Member | no data | no data | no data | |
| Independent Director | 1.8yrs | no data | no data | |
| Scientific Board Member | less than a year | no data | no data |
1.8yrs
Average Tenure
Experienced Board: 6885's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 06:50 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BRIM Biotechnology, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|